We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$57.2B
AUM Growth
+$551M
Cap. Flow
-$331M
Cap. Flow %
-0.58%
Top 10 Hldgs %
31.76%
Holding
1,006
New
143
Increased
295
Reduced
385
Closed
137

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$247M
2
BMY icon
Bristol-Myers Squibb
BMY
+$183M
3
WCC
WESCO International
WCC
+$178M
4
GILD icon
Gilead Sciences
GILD
+$154M
5
DAL icon
Delta Air Lines
DAL
+$145M

Top Sells

Rank Stock Value
1
MRO
Marathon Oil Corporation
MRO
+$221M
2
MMM icon
3M
MMM
+$157M
3
MRSH
Marsh
MRSH
+$120M
4
JNJ icon
Johnson & Johnson
JNJ
+$106M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$105M

Sector Composition

Rank Sector Weight
1 Technology 29.09%
2 Healthcare 13.87%
3 Financials 11.48%
4 Consumer Discretionary 10.65%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSIC icon
301
Henry Schein
HSIC
$9.83B
$33.9M 0.06%
490,313
+241,556
+97% +$17.3M
KDP icon
302
Keurig Dr Pepper
KDP
$41.3B
$33.8M 0.06%
1,051,900
+162,000
+18% +$5.48M
CCI icon
303
Crown Castle
CCI
$32.7B
$33.7M 0.06%
371,060
-38,600
-9% -$4.04M
COGT icon
304
Cogent Biosciences
COGT
$7.14B
$33.5M 0.06%
4,300,000
+233,966
+6% +$2.33M
CPRT icon
305
Copart
CPRT
$26.9B
$33.5M 0.06%
584,100
+91,700
+19% +$5.22M
AON icon
306
Aon
AON
$76.5B
$33.1M 0.06%
+92,069
New +$33.9M
EA icon
307
Electronic Arts
EA
$32.6M 0.06%
222,966
-3,700
-2% -$569K
SW
308
Smurfit Westrock
SW
$24.6B
$32.6M 0.06%
604,618
+139,529
+30% +$7.11M
STZ icon
309
Constellation Brands
STZ
$22.6B
$32.2M 0.06%
145,867
+18,000
+14% +$4.28M
ZBRA icon
310
Zebra Technologies
ZBRA
$17.2B
$32.1M 0.06%
83,211
-5,400
-6% -$2.09M
VRDN icon
311
Viridian Therapeutics
VRDN
$2.49B
$32M 0.06%
1,670,000
+465,000
+39% +$10.1M
KEY icon
312
KeyCorp
KEY
$24.3B
$31.8M 0.06%
1,856,169
+215,728
+13% +$3.87M
REGN icon
313
Regeneron Pharmaceuticals
REGN
$79.5B
$31.6M 0.06%
44,349
-125,290
-74% -$105M
EDR
314
DELISTED
Endeavor Group Holdings, Inc.
EDR
$31.5M 0.06%
1,006,992
-1,452,679
-59% -$43.3M
NVMI
315
Nova
NVMI
$12.1B
$31.4M 0.05%
159,197
-168,362
-51% -$32.4M
STWD icon
316
Starwood Property Trust
STWD
$5.91B
$31.2M 0.05%
1,648,904
+248,904
+18% +$4.93M
URGN icon
317
UroGen Pharma
URGN
$2.22B
$31.2M 0.05%
2,928,086
-807,655
-22% -$9.67M
SBAC icon
318
SBA Communications
SBAC
$19.4B
$31.1M 0.05%
152,400
+51,100
+50% +$11.5M
IDYA icon
319
IDEAYA Biosciences
IDYA
$3.49B
$30.8M 0.05%
1,200,094
+220,000
+22% +$6.23M
OCUL icon
320
Ocular Therapeutix
OCUL
$1.92B
$30.7M 0.05%
3,600,000
-150,000
-4% -$1.46M
MGTX icon
321
MeiraGTx Holdings
MGTX
$1.18B
$30.7M 0.05%
5,034,578
-194,521
-4% -$1.14M
MREO
322
Mereo BioPharma
MREO
$48.8M
$30.5M 0.05%
8,715,013
-1,000,000
-10% -$3.93M
ZVRA icon
323
Zevra Therapeutics
ZVRA
$702M
$30.4M 0.05%
3,650,000
+3,001,000
+462% +$25.6M
LEN icon
324
Lennar Class A
LEN
$20.4B
$30.4M 0.05%
230,480
-234,181
-50% -$38.1M
VLO icon
325
Valero Energy
VLO
$87.2B
$30.1M 0.05%
245,800
+3,800
+2% +$508K
11 12
13
14 15

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Adage Capital Partners held 1,006 positions worth $57.2B, up 0.97% from $56.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q4 2024 filing shows 143 new, 295 increased, 385 reduced and 137 closed positions. Its largest new stake was Gilead Sciences: 1,714,130 shares worth $158M. The largest sale was Marathon Oil Corporation, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2024 buy was Gilead Sciences: 1,714,130 shares worth $158M.
  • Adage Capital Partners added most to ConocoPhillips in Q4 2024, an estimated $247M increase.
  • Adage Capital Partners's biggest Q4 2024 reduction was 3M, cutting an estimated $157M.
  • Adage Capital Partners fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $221M.
  • Adage Capital Partners's ten largest holdings make up 32% of its $57.2B portfolio in Q4 2024.
  • Adage Capital Partners opened 143 new positions and closed 137 in Q4 2024.
  • Adage Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $57.2B.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.